Related Experiment Video

Updated: Jul 19, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Prevalence of chronic kidney disease in Thai adult population

Anutra Chittinandana1, Worawon Chailimpamontree, Preecha Chaloeiphap

  • 1Renal Division, Department of Medicine, Bhumibol Adulyadej Hospital, Royal Thai Air Force, Bangkok, Thailand. Anutra.rtaf@gmail.com

Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
|October 19, 2006
PubMed

Insights

Chronic kidney disease (CKD) is prevalent in Thailand

Area of Science:

  • Nephrology
  • Public Health
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) poses a significant global health challenge.
  • Limited large-scale data exists on pre-dialysis CKD prevalence in Thailand.
  • This study addresses the data gap in a specific Thai population.

Purpose of the Study:

  • To determine the prevalence of pre-dialysis CKD among Royal Thai Air Force (RTAF) personnel in Bangkok.
  • To identify associated risk factors and demographic characteristics of CKD in this cohort.
  • To compare the performance of different CKD diagnostic equations.

Main Methods:

  • Descriptive analysis of clinical and laboratory data from 15,612 RTAF personnel (2002-2003).
  • Exclusion of pilots and aircrew; focus on personnel working in Bangkok.
  • CKD staging based on Kidney Disease Outcome Quality Initiative (K/DOQI) guidelines, using Cockcroft-Gault and MDRD formulas.

Main Results:

  • CKD prevalence was 9.1% (Cockcroft-Gault) and 4.6% (MDRD).
  • Common comorbidities included hypertension (45.8%) and hypercholesterolemia (28.2%).
  • CKD patients were older and had higher BMI, blood pressure, and blood sugar.

Conclusions:

  • CKD is not uncommon in the studied RTAF population.
  • Significant discrepancies exist between Cockcroft-Gault and MDRD equations for GFR estimation in Thais.
  • Further evaluation of GFR equations and proteinuria detection methods is recommended for the Thai population.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...